Travere Therapeutics
TVTX
TVTX
168 hedge funds and large institutions have $1.7B invested in Travere Therapeutics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 60 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
–
Holders Change %
0%
% of All Funds
2.66%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
22
Increased
62
Reduced
60
Closed
21
Calls
$4.43M
Puts
$2.43M
Net Calls
+$2M
Net Calls Change
+$1.99M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$22.7M |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$17.8M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$17.6M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$16.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$15.8M |
